The Commission has presented a new Strategy on Combatting Trafficking in Human Beings (2021-2025), focusing on preventing the crime, bringing traffickers to justice and protecting and empowering victims. Between 2017 and 2018, there were more than 14,000 registered victims within the European Union. Globally, traffickers make estimated profits of €29.4 billion in a single year. With demand for exploitation expected to continue, traffickers moving their acts online and the pandemic likely to create the conditions for increased exploitation, today's strategy sets out the measures that will allow the EU and its member states to continue strengthening their response.
Promoting our European Way of Life Vice President Margaritis Schinas said: "Fighting trafficking in human beings is part of our work towards building a Europe that protects. Traffickers prey on people's vulnerabilities. With today's Strategy, we are taking a three-pronged approach, using legislation, policy and operational support and funding in tandem to reduce demand, break criminal business, and empower victims of this abominable crime."
Home Affairs Commissioner Ylva Johansson said: "Trafficking in human beings is a crime that should have no place in our societies. Yet, criminals continue to traffic victims, mainly women and children, and mostly for sexual exploitation. We owe the victims protection, and we need to bring to justice the perpetrators who treat human beings as a commodity. We will look at the rules in place to check if they are still fit for purpose and we will assess the possibility of criminalising the use of exploited services from trafficking victims.”
The strategy builds on the EU's comprehensive legal and policy framework in place to address trafficking in human beings, rooted in the Anti-trafficking Directive. The Commission will continue to support member states in the implementation of the Directive and, if necessary, will propose revisions to make sure it is fit for purpose. The EU anti-trafficking coordinator will continue to play a key role in the implementation of this strategy.
In addition, the Strategy focuses on:
- Reducing demand that fosters trafficking: The Commission will assess the possibility of establishing minimum EU rules criminalising the use of exploited services of trafficking victims and will organize - together with national authorities and civil society organiZations - a prevention campaign targeting high-risk sectors. The Commission will also consider strengthening Employers' Sanctions Directive and will propose legislation on corporate governance to clarify the responsibilities of companies and will provide guidance on due diligence to help prevent forced labour.
- Breaking the business model of traffickers, online and offline: The Commission will conduct a dialogue with internet and technology companies to reduce the use of online platforms for the recruitment and exploitation of victims. The Commission will encourage systematic training of law enforcement and judicial practitioners on detecting and addressing trafficking in human beings.
- Protecting, supporting and empowering the victims with a specific focus on women and children: The Strategy seeks to improve the early identification of victims and their referral for further assistance and protection, strengthen victim empowerment programmes and facilitate re-integration. The Commission will also fund gender-specific and child-sensitive training to help police, social workers, border guards or healthcare staff detect victims.
- Promoting international cooperation: With half of the victims identified in the EU being non-EU citizens, cooperation with international partners is key to address trafficking. The EU will use a range of foreign policy instruments and operational cooperation to help combat trafficking in countries of origin and transit including through dedicated human rights and security dialogues, enhanced cooperation with the Council of Europe and regular and targeted communication, action and exchange of information with EU delegations in partner countries. The upcoming Action Plan against Migrant Smuggling will also help disrupt traffickers' business in moving victims for exploitation to Europe.
Trafficking in human beings remains a serious threat in the EU despite progress achieved in the past years. Victims are mainly women and girls trafficked for sexual exploitation. The third report on the progress made in the fight against trafficking in human beings, published in October 2020, provides a factual overview on the progress made, presents patterns and challenges and key issues in addressing trafficking in human beings in the EU.
As trafficking in human beings is often perpetuated by organised crime groups, the Strategy on Combatting Trafficking in Human Beings is closely linked to the EU Strategy to Tackle Organized Crime also presented. Protecting society from organised crime, including tackling trafficking in human beings, is a priority under the EU Security Union Strategy.
The new Pact on Migration and Asylum also highlighted the importance of the early identification of potential non-EU victims of trafficking in human beings.
Communication on the EU Strategy on Combatting Trafficking in Human Beings 2021-2025
MEMO: EU Strategy to tackle Organised Crime & EU Strategy on combatting Trafficking in Human Beings
Factsheet: Fighting Trafficking in Human Beings
Press release: Fight against organized crime: New 5-year strategy for boosting cooperation across the EU and for better use of digital tools for investigations
Third report on the progress made in the fight against trafficking in human beings
Coronavirus: Commission signs contract to procure monoclonal anti-body treatment
Yesterday (27 July), the Commission signed a joint procurement framework contract with the pharmaceutical company Glaxo Smith Kline for the supply of sotrovimab (VIR-7831), an investigational monoclonal antibody therapy, developed in collaboration with VIR biotechnology. It is part of the first portfolio of five promising therapeutics announced by the Commission in June 2021, and is currently under rolling review by the European Medicines Agency. 16 EU member states are participating in the procurement for the purchase of up to 220,000 treatments. Sotrovimab can be used for the treatment of coronavirus patients with mild symptoms who do not require supplemental oxygen, but who are at high risk for severe COVID-19. Ongoing studies suggest that early treatment can reduce the number of patients that progress to more severe forms and require hospitalisation or admission to the intensive care units.
Health and Food Safety Commissioner Stella Kyriakides said: “We committed in our COVID-19 Therapeutics Strategy to have at least three new therapeutics authorised by October. We are now delivering a second framework contract that brings monoclonal antibodies treatments to patients. Alongside vaccines, safe and effective therapeutics will play a pivotal role in Europe's return to a new normal.”
Monoclonal antibodies are proteins conceived in the laboratory that mimic the immune system's ability to fight the coronavirus. They attach to the spike protein and thus block the virus' attachment to the human cells. The European Commission concluded nearly 200 contracts for different medical countermeasures worth over €12 billion.
Under the current framework contract with Glaxo Smith Kline, member states can purchase sotrovimab (VIR-7831) if and when needed, once it has received either emergency use authorisation in the member state concerned or a (conditional) marketing authorisation at EU level from the European Medicines Agency. Further information can be found here.
Water management: Commission consults to update lists of pollutants affecting surface and ground water
The Commission has launched an online public consultation to seek views on the upcoming review of the lists of pollutants occurring in surface and ground waters, as well as on corresponding regulatory standards. This initiative is particularly important for implementing the recently adopted Zero Pollution Action Plan as part of the European Green Deal, and wider efforts to secure the more efficient and safer use of water.
Environment, Oceans and Fisheries Commissioner Virginijus Sinkevičius said: “All Europeans should benefit from clean water. Ensuring good quality of surface and groundwater in Europe is paramount for human health and for the environment. Pollution caused by pesticides, manmade chemicals or from residues of pharmaceuticals must be avoided as much as possible. We want to hear your views on how this can best be achieved.”
A recent evaluation (‘fitness check') in December 2019, found EU water legislation to be broadly fit for purpose. However, improvement is needed on aspects such as investment, implementing rules, integrating water objectives into other policies, administrative simplification and digitalisation. This revision aims to address some of the shortcomings in relation to chemical pollution and the legal obligation to regularly review the lists of pollutants, as well as to help accelerate implementation. The public consultation is open for feedback until 1 November 2021. More information is in this news release.
COVID-19 vaccines: Launch of the interactive map on vaccine production capacities in the EU
The Commission has published an interactive map showcasing COVID-19 vaccine production capacities in the EU, along the entire supply chain. The mapping tool is based on data gained through the work of the Task Force for Industrial Scale-up of COVID-19 vaccine production, on data collected during the matchmaking event organised by the Commission in March, as well as publicly available information and information shared by member states. This data will be complemented and updated as further information becomes available.
Commissioner Breton, responsible for the Internal Market and head of the Task Force, said: “With more than one billion vaccine doses produced, our industry has helped the EU become the world's most vaccinated continent and the world's leading exporter of COVID-19 vaccines. This interactive map, featuring hundreds of EU-based manufacturers, suppliers and distributors, shows the breadth of the industrial ecosystem, as well as the potential for new industrial partnerships to further boost our health emergency preparedness.”
The Task Force categorized the companies based on their main area of activity, thus companies may have more capacities than those reflected in the map. The Task Force for Industrial Scale-up of COVID-19 vaccine production was set up by the Commission in February 2021 to ramp up production capacity for COVID-19 vaccines in the EU, acting as a one-stop-shop for manufacturers seeking support, and to identify and address bottlenecks in terms of production capacity and supply chain. The interactive map is available here.
Japan5 days ago
Tokyo opening ceremony reflects the true purpose of the Olympics
Brexit2 days ago
EU backs Ireland as UK searches for solutions to Northern Ireland Protocol dilemma
EU Reporter3 days ago
Summertime and the livin’ is… not always so easy
coronavirus2 days ago
Ensuring smooth air travel while checking EU Digital COVID Certificates: New guidelines for member states
Energy2 days ago
US and Germany strike Nord Stream 2 pipeline deal to push back on Russian 'aggression'
coronavirus3 days ago
Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants
coronavirus1 day ago
How the Delta variant upends assumptions about the coronavirus
Kazakhstan1 day ago
Voters go to rural polls for first time in Kazakhstan